Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Progress in Transplantation (Aliso Viejo, Calif.)|August 30, 2022
Assessing the Effectiveness of a Primary Care Provider Office-Based Intervention for Increasing Organ Donor Registration Rates in Two New York State CountiesMichael McCabe, M Katherine Dokus, Nancy J Ryan, et al.Open Forum Infectious Diseases|April 20, 2018
Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus InfectionWilliam A Fischer, Jerry Brown, David Alain Wohl, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 30, 2020
Individual and Composite Adverse Pregnancy Outcomes in a Randomized Trial on Isoniazid Preventative Therapy Among Women Living With Human Immunodeficiency VirusGerhard Theron, Grace Montepiedra, Lisa Aaron, et al.Journal of Substance Abuse Treatment|December 3, 2014
Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community correctionsPeter D Friedmann, Donna Wilson, Hannah K Knudsen, et al.Medrxiv : the Preprint Server for Health Sciences|June 23, 2021
Molnupiravir, an Oral Antiviral Treatment for COVID-19William Fischer, Joseph J Eron, Wayne Holman, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 7, 2019
Long-term Complications of Ebola Virus Disease: Prevalence and Predictors of Major Symptoms and the Role of InflammationSam Tozay, William A Fischer, David A Wohl, et al.Science Translational Medicine|December 23, 2021
A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusWilliam A Fischer, Joseph J Eron, Wayne Holman, et al.Cancers|July 13, 2024
Preclinical Therapeutic Efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR Inhibition in NeuroblastomaStacey Stauffer, Jacob S Roth, Edjay R Hernandez, et al.Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.Science Signaling|February 11, 2025
Targeting c-MYC and gain-of-function p53 through inhibition or degradation of the kinase LZK suppresses the growth of HNSCC tumorsAmy L Funk, Meghri Katerji, Marwa Afifi, et al.Pageof 4